USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: Extend Biosciences Inc.
City: Cambridge
State: MA
Zip+4: 02139-
Woman-Owned: Yes
Minority-Owned: No
HUBZone-Owned: No
Phone: (732) 599-8580

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $837,950.00 3
SBIR Phase II $499,999.00 1

Award List:

Enhancing the Pharmacokinetic Profile of Protein-based Drugs

Award Year / Program / Phase: 2013 / SBIR / Phase I
Agency: DOD
Principal Investigator: Laura M. Hales, Chief Scientific Officer – (732) 599-8581
Award Amount: $99,999.00
Abstract:
Many protein-based drugs have limited efficacy due to a short half-life or require intravenous delivery because of low bioavailability when given subcutaneously. Extend Biosciences is developing proprietary carrier molecules that will allow proteins to access a transport pathway for efficient… More

Monitor for Multiple Biomarkers for Detection of Alcohol Consumption

Award Year / Program / Phase: 2013 / SBIR / Phase I
Agency: HHS
Principal Investigator: Laura M. Hales – 212-305-1482
Award Amount: $449,649.00
Abstract:
DESCRIPTION (provided by applicant): Chronic alcohol consumption can cause progressive liver damage, resulting in steatohepatitis and cirrhosis, which can lead to other more fatal complications such as hepatocellular carcinoma (HCC). Progression of alcoholic liver disease (ALD), like many chronic… More

Efficacy and Safety of an Aerosolized Recombinant Butyrylcholinesterase Pretreatm

Award Year / Program / Phase: 2013 / SBIR / Phase I
Agency: HHS
Principal Investigator: Tarik Soliman – 732-599-8580
Award Amount: $288,302.00
Abstract:
DESCRIPTION (provided by applicant): Cachexia is a complex syndrome characterized by involuntary weight loss and skeletal muscle wasting that leads to fatigue, weakness and a loss of appetite that is not reversed by increased caloric consumption. More thanhalf of all cancer patients develop cachexia… More

Enhancing the Pharmacokinetic Profile of Protein-based Drugs

Award Year / Program / Phase: 2014 / SBIR / Phase II
Agency: DOD
Principal Investigator: Laura H. Ph.D., Founder, Chief Business O – (732) 599-8581
Award Amount: $499,999.00
Abstract:
Many protein-based drugs have limited efficacy due to a short half-life or require intravenous delivery because of low bioavailability. Extend Biosciences is developing proprietary carrier molecules that allow proteins to access an intrinsic transport pathway for efficient delivery to the vascular… More